http://pharmaweblog.com/blog/2006/06/21/the-argument-for-evidence-and-science-to-drive-pharma-rd-strategy/ Pharmaceutical and biotech science and business Wed, 20 Aug 2008 11:25:54 +0000 http://wordpress.org/?v=2.0.2 http://pharmaweblog.com/blog/2006/06/21/the-argument-for-evidence-and-science-to-drive-pharma-rd-strategy/#comment-16 Sat, 24 Jun 2006 09:42:00 +0000 http://pharmaweblog.com/blog/2006/06/21/the-argument-for-evidence-and-science-to-drive-pharma-rd-strategy/#comment-16 I agree with your discussion on the limitations of the present methods used to develop Pharma strategy. Your computer-assisted approach sounds interesting but your example was not compelling since it implied that if a Pharma had a marketable first-in-class compound, they might sit on it to ensure a better profit. Marketable drugs are so rare it is hard to imagine any company would deliberately delay going to market. Rather than maximizing profits, can your approach better manage the risk in this business? That's really what is needed. I agree with your discussion on the limitations of the present methods used to develop Pharma strategy. Your computer-assisted approach sounds interesting but your example was not compelling since it implied that if a Pharma had a marketable first-in-class compound, they might sit on it to ensure a better profit. Marketable drugs are so rare it is hard to imagine any company would deliberately delay going to market.
Rather than maximizing profits, can your approach better manage the risk in this business? That’s really what is needed.

]]>